Present and Future of Immunotherapy for Triple-Negative Breast Cancer

Sriramulu, Sushmitha; Thoidingjam, Shivani; Speers, Corey; Nyati, Shyam

doi:10.3390/cancers16193250

Public

Present and Future of Immunotherapy for Triple-Negative Breast Cancer

Published in Cancers • Sep 24, 2024

Authors:

Sushmitha Sriramulu

Shivani Thoidingjam

Corey Speers

Abstract

Triple-negative breast cancer (TNBC) lacks the expression of estrogen receptors (ERs), human epidermal growth factor receptor 2 (HER2), and progesterone receptors (PRs). TNBC has the poorest prognosis among breast cancer subtypes and is more likely to respond to immunotherapy due to its higher expre...

Subject

Triple-negative breast cancer

Immunotherapy

Medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!